Table 2.

OVA treatment increases the volume and number of pGSK (+) ASM

Treatment	PBS	OVA
pGSK (+) ASM Vv	0.001±0.0001	0.012±0.0008†
pGSK (−) ASM Vv	0.004±0.0005	0.003±0.0007
pGSK (+) ASM lung volume, ml	0.001±0.0002	0.015±0.001†
pGSK (+) ASM Nv	1.88×106±1.52×105	9.58×106±4.19×105‡
pGSK (+) ASM cells per lung	1.59×106±1.84×105	11.2×106±3.56×105†
pGSK (−) ASM Nv	5.71×106±6.61×105	3.81×106±8.29×105*
pGSK (+) ASM Vv/Nv, μm3	768±109	1230±193‡
pGSK (−) ASM Vv/Nv, μm3	802±96	722±211

Values are means ± SE; n = 6 for each condition; different from PBS group,

^*P < 0.05,

^†P < 0.002,

^‡P < 0.001, unpaired t-test. pGSK, phospho-Ser⁹ glycogen synthase kinase-3β.